Tesaro Secures $20,000,000 Series A Funding

  • Feed Type
  • Date
    5/26/2010
  • Company Name
    Tesaro
  • Mailing Address
    135 Clarendon St. Boston, MA 02116
  • Company Description
    TESARO is a privately held oncology-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of cancer patients by developing and providing safer and more effective therapeutics and supportive care products.
  • Website
    http://www.tesarobio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company will use the funding to acquire, develop and commercialize cancer therapeutics and supportive care products.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Undisclosed

Trending on Xconomy